The relationship between observed signs of impairment and THC concentration in oral fluid

Drug and Alcohol Dependence

Volumn 144, Issue , 2014, Pages 231-238

  Fierro, Inmaculada ^a   González Luque, Juan Carlos ^b   Álvarez, F Javier ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b Ministerio del Interior   (Spain)

Author keywords

Automobile driver examination; Cannabinoids; Diagnostic test; Psychomotor impairment; Traffic accidents

Indexed keywords

ALCOHOL; DRONABINOL; BIOLOGICAL MARKER;

ARTICLE; BEHAVIOR; BREATH ANALYSIS; CANNABIS ADDICTION; CAR DRIVER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FACIAL EXPRESSION; HUMAN; POLICE; PSYCHOMOTOR DISORDER; RETROSPECTIVE STUDY; SALIVA ANALYSIS; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; SPANIARD; SPEECH ANALYSIS; ADVERSE EFFECTS; CAR DRIVING; CHEMISTRY; DRINKING BEHAVIOR; FEMALE; MALE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SALIVA; TRAFFIC ACCIDENT; TRENDS; YOUNG ADULT;

ACCIDENTS, TRAFFIC; ALCOHOL DRINKING; AUTOMOBILE DRIVING; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DRONABINOL; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SALIVA; YOUNG ADULT;

EID: 84909943855     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.09.770     Document Type: Article

References (39)

1. Asbridge M., Hayden J.A., Cartwright J.L. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 2012, 344:e536.
2. Bramness J.G., Khiabani H.Z., Morland J. Impairment due to cannabis and ethanol: clinical signs and additive effects. Addiction 2010, 105:1080-1087.
3. Bosker W.M., Theunissen E.L., Conen S., Kuypers K.P.C., Jeffery W.K., Walls H.C., Kauert G.F., Toennes S.W., Moeller M.R., Ramaekers J.G. A placebo-controlled study to asses Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid. Psychopharmacology 2012, 223:439-446.
4. Burns, M., Moskowitz, H., 1977. Psychophysical Test for DWI Arrest. U.S. Department of Transportation, National Highway Traffic safety Administration, Washington, D.C.
5. Burns M. Sobriety test for the presence of drugs. Alcohol Drugs Driving 1987, 3:25-29.
6. Choo R.E., Huestis M.A. Oral fluid as a diagnostic tool. Clin. Chem. Lab. Med. 2004, 42:1273-1287.
7. Chu M., Gerostamoulos D., Beyer J., Rodda L., Boorman M., Drummer O.H. The incidence of drugs of impairment in oral fluid from random roadside testing. Forensic Sci. Int. 2012, 215:28-31.
8. Concheiro M., de Castro A., Quintela O., Cruz A., Lopez-Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem 2008, 391:2329-2338.
9. Crouch D.J. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci. Int 2005, 150:165-173.
10. Downey L.A., King R., Papafotiou K., Swann P., Ogden E., Boorman M., Stough C. The effects of cannabis and alcohol on simulated driving: influences of dose and experience. Accid. Anal. Prev 2012, 50:879-886.
11. DRUID, 2007. Working Paper. Uniform Design and Protocols for Carrying Out Case-Control Studies. Available on line at: http://www.druid-project.eu/Druid/EN/deliverales-list/downloads/deliverable_2_1_2.pdf?_blob=publicationFile (accesses 09.06.14).
12. Drummer O.H., Gerostamoulos J., Batziris H., Chu M., Caplehorn J., Robertson M.D., Swann P. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid. Anal. Prev. 2004, 36:239-248.
13. European Commission. Mobility and Transport: Road Safety, 2014. Legal alcohol limits for the general driver population, Available at: http://ec.europa.eu/transport/road_safety/specialist/knowledge/alcohol/prevalence:amp_rate_of_alcohol_consumption/the_legal_limit_en.htm (accesses 21.07.14).
14. European Monitoring Centre for Drugs and Drug Addiction, 2012. Driving under the influence of drugs, alcohol and medicines in Europe - findings from the DRUID project, Lisbon. Available on line at: http://www.emcdda.europa.eu/publications/thematic-papers/druid (accesses 09.06.14).
15. Gjerde H., Mordal J., Christophersen A.S., Bramness J.G., Morland J. Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device. J. Anal. Toxicol. 2010, 34:204-209.
16. Gjerde H., Verstraete A. Can the prevalence of high blood drug concentrations in a population be estimated by analysing oral fluid?. A study of tetrahydrocannabinol and amphetamine. Forensic Sci. Int. 2010, 195:153-159.
17. Gjerde H., Verstraete A.G. Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: a study of tetrahydrocannabinol and amphetamine. Forensic Sci. Int 2011, 212:e26-e30.
18. Gomez-Talegon T., Fierro I., Gonzalez-Luque J.C., Colas M., Lopez-Rivadulla M., Javier Alvarez F. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study. Forensic Sci. Int. 2012, 223:106-113.
19. Grotenhermen F., Leson G., Berghaus G., Drummer O.H., Kruger H.P., Longo M., Moskowitz H., Perrine B., Ramaekers J.G., Smiley A., Tunbridge R. Developing limits for driving under cannabis. Addiction 2007, 102:1910-1917.
20. Houwing, S., Hagenzieker, M., Mathijssen, R., Bernhoft, I.M., Hels, T., Janstrup, K., Van der Linden, T., Legrand, S.A., Verstraete, A., 2011. Prevalence of Alcohol and Other Psychoactive Substances in Drivers in General Traffic. Part I: General Results and Part II: Country Reports, DRUID Deliverable 2.2.3. Available on line at: http://www.druid-project.eu/Druid/EN/deliverales-list/downloads/Deliverable_2_2_3_Part1.pdf?_blob=publicationFile and http://www.druid-project.eu/Druid/EN/deliverales-list/downloads/Deliverable_2_2_3_Part2.pdf?_blob=publicationFile (accesses 09.06.14).
21. Hunault C.C., Mensinga T.T., Bocker K.B., Schipper C.M., Kruidenier M., Leenders M.E., de Vries I., Meulenbelt J. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69mg delta-9-tetrahydrocannabinol (THC). Psychopharmacology (Berl.) 2009, 204:85-94.
22. Koski A., Vuori E., Ojanpera I. Relation of postmortem blood alcohol and drug concentrations in fatal poisonings involving amitriptyline, propoxyphene and promazine. Hum. Exp. Toxicol. 2005, 24:389-396.
23. Laumon B., Gadegbeku B., Martin J.L., Biecheler M.B. Cannabis intoxication and fatal road crashes in France: population based case-control study. BMJ 2005, 331:1371.
24. Mathijssen, R., Sjoerd, H., 2005. The Prevalence and Relative Risk of Drink and Drug Driving in the Netherlands: A Case-Control Study in the Tilburg Police District. SWOV Institute for Road Safety Research, Leidschemdam. The Netherlands. Available on line at: http://www.swov.nl/rapport/r-2005-09.pdf (accesses 16.06.14).
25. Möller, M., 1998. Drogenerkennung im Strassenverkehr. Berichte der Bundesanstalt für Strassenwesen, Mensch und Sicherheit M 96. Bundesanstalt für Strassenwesen BASt, Bergisch Gladbach.
26. NHTSA, 2001. Development of a Standardized Field Sobriety Test (SFST). Training Management System. DOT HS 809 400. Available at: http://www.nhtsa.gov/people/injury/alcohol/sfst/introduction.htm (accesses 09.06.14).
27. Papafotiou K., Carter J.D., Stough C. An evaluation of the sensitivity of the Standardised Field Sobriety Tests (SFSTs) to detect impairment due to marijuana intoxication. Psychopharmacology (Berl.) 2005, 180:107-114.
28. Papafotiou K., Carter J.D., Stough C. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood. Forensic Sci. Int. 2005, 155:172-178.
29. Pil K., Verstraete A. Current developments in drug testing in oral fluid. Ther. Drug Monit. 2008, 30:196-202.
30. Raes, E., Van den Neste, T., Verstraete, A.G., 2008. Drug use, Impaired Driving and Traffic Accidents. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.
31. Ramaekers J.G., Berghaus G., van Laar M., Drummer O.H. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004, 73:109-119.
32. Ramaekers J.G., Moeller M.R., van Ruitenbeek P., Theunissen E.L., Schneider E., Kauert G. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 2006, 85:114-122.
33. Tzambazis, K., Stough, C., 2002. The SFST and driving ability. Are they related? In: Mayhew, D.R., Dussault, C. (Eds.), ICADTS, Montreal. 16th International Conference on Alcohol Drugs and Traffic safety. Proceedings 2, 397-400.
34. Verstraete A.G. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci. Int. 2005, 150:143-150.
35. Vindenes V., Lund H.M., Andresen W., Gjerde H., Ikdahl S.E., Christophersen A.S., Oiestad E.L. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci. Int. 2012, 219:165-171.
36. Walsh, J., Cangianelli, L., 2002. New training in detection of illicit drugs in drivers. In: Mayhew, D. R., Dussault, C. (Eds), Alcohol, drugs and traffic safety - T'2002, Société de l'assurance automobile du Québec, Québec, pp. 387-390.
37. Walsh J.M., de Gier J.J., Christopherson A.S., Verstraete A.G. Drugs and driving. Traffic Inj. Prev. 2004, 5:241-253.
38. Watling C.N., Palk G.R., Freeman J.E., Davey J.D. Applying Stafford and Warr's reconceptualization of deterrence theory to drug driving: can it predict those likely to offend?. Accid. Anal. Prev. 2010, 42:452-458.
39. Wille S.M., Raes E., Lillsunde P., Gunnar T., Laloup M., Samyn N., Christophersen A.S., Moeller M.R., Hammer K.P., Verstraete A.G. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther. Drug Monit. 2009, 31:511-519.